Here we provide a selection of scientific publications related to IOZK immunotherapy. You can use the filters to make a selection according to tumor types and methods, or enter search terms.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002010-09-21 / Int J Hyperthermia 2010;26(8):748-64https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2010-09-21 / Int J Hyperthermia 2010;26(8):748-642010-09-21 00:00:002019-02-15 10:00:35Measurement and mathematical modeling of thermally induced injury and heat shock protein expression kinetics in normal and cancerous prostate cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002010-09-07 / Cancer Res. 2010 Sep;70(18):7093-101https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2010-09-07 / Cancer Res. 2010 Sep;70(18):7093-1012010-09-07 00:00:002019-02-15 08:40:15IFN{gamma} markedly cooperates with intratumoral dendritic cell vaccine in dog tumor models
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002010-09-01 / Dan Med Bull 2010 Sep;57(9):B4171https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2010-09-01 / Dan Med Bull 2010 Sep;57(9):B41712010-09-01 00:00:002019-02-15 08:46:06Dendritic cell vaccination of patients with metastatic colorectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002010-09-01 / PLoS ONE 2010 Sep;5(9)https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2010-09-01 / PLoS ONE 2010 Sep;5(9)2010-09-01 00:00:002019-02-15 08:52:57Harnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002010-08-24 / Clin. Cancer Res. 2010 Oct;16(20):5067-78https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2010-08-24 / Clin. Cancer Res. 2010 Oct;16(20):5067-782010-08-24 00:00:002019-02-15 08:49:24Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002010-08-01 / Zhonghua Nan Ke Xue 2010 Aug;16(8):698-704https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2010-08-01 / Zhonghua Nan Ke Xue 2010 Aug;16(8):698-7042010-08-01 00:00:002019-02-15 08:52:54[Auto-dendritic cell vaccines pulsed with PSA, PSMA and PAP peptides for hormone-refractory prostate cancer]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002010-08-01 / Nat. Rev. Immunol. 2010 Aug;10(8):580-93https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2010-08-01 / Nat. Rev. Immunol. 2010 Aug;10(8):580-932010-08-01 00:00:002019-02-15 08:52:58Prostate cancer as a model for tumour immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002010-08-01 / Sheng Wu Gong Cheng Xue Bao 2010 Aug;26(8):1031-6https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2010-08-01 / Sheng Wu Gong Cheng Xue Bao 2010 Aug;26(8):1031-62010-08-01 00:00:002019-02-15 09:21:42[Progress in using Newcastle disease virus for tumor therapy: a review]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002010-08-01 / Zhongguo Fei Ai Za Zhi 2010 Aug;13(8):773-6https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2010-08-01 / Zhongguo Fei Ai Za Zhi 2010 Aug;13(8):773-62010-08-01 00:00:002019-02-15 09:21:46[Anti-tumor immunity of Newcastle disease virus HN protein is influenced by differential subcellular targeting]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002010-08-01 / Surgery 2010 Aug;148(2):325-34https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2010-08-01 / Surgery 2010 Aug;148(2):325-342010-08-01 00:00:002010-08-01 00:00:00Hyperthermia potentiates oncolytic herpes viral killing of pancreatic cancer through a heat shock protein pathway
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002010-07-27 / Pigment Cell Melanoma Res 2010 Oct;23(5):607-19https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2010-07-27 / Pigment Cell Melanoma Res 2010 Oct;23(5):607-192010-07-27 00:00:002010-07-27 00:00:00Dendritic cell vaccination in human melanoma: relationships between clinical effects and vaccine parameters
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002010-07-07 / Br. J. Haematol. 2010 Sep;150(5):554-64https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2010-07-07 / Br. J. Haematol. 2010 Sep;150(5):554-642010-07-07 00:00:002019-02-15 08:50:54Optimizing dendritic cell-based immunotherapy in multiple myeloma: intranodal injections of idiotype-pulsed CD40 ligand-matured vaccines led to induction of type-1 and cytotoxic T-cell immune responses in patients
Genetically engineered oncolytic Newcastle disease virus effectively induces sustained remission of malignant pleural mesothelioma
Measurement and mathematical modeling of thermally induced injury and heat shock protein expression kinetics in normal and cancerous prostate cells
IFN{gamma} markedly cooperates with intratumoral dendritic cell vaccine in dog tumor models
Dendritic cell vaccination of patients with metastatic colorectal cancer
Harnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancer
Immunological response after therapeutic vaccination with WT1 mRNA-loaded dendritic cells in end-stage endometrial carcinoma
Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patients
Dendritic cells-mediated CTLs targeting hepatocellular carcinoma stem cells
The hemagglutinin-neuraminidase gene of Newcastle Disease Virus: a powerful molecular adjuvant for DNA anti-tumor vaccination
Ascorbate exerts anti-proliferative effects through cell cycle inhibition and sensitizes tumor cells towards cytostatic drugs
Global sensitivity analysis and model-based reactive scheduling of targeted cancer immunotherapy
[Auto-dendritic cell vaccines pulsed with PSA, PSMA and PAP peptides for hormone-refractory prostate cancer]
Prostate cancer as a model for tumour immunotherapy
[Progress in using Newcastle disease virus for tumor therapy: a review]
[Anti-tumor immunity of Newcastle disease virus HN protein is influenced by differential subcellular targeting]
Hyperthermia potentiates oncolytic herpes viral killing of pancreatic cancer through a heat shock protein pathway
Dendritic cell vaccination in human melanoma: relationships between clinical effects and vaccine parameters
Human myeloid dendritic cells for cancer therapy: does maturation matter?
Induction of complete and molecular remissions in acute myeloid leukemia by Wilms‘ tumor 1 antigen-targeted dendritic cell vaccination
Optimizing dendritic cell-based immunotherapy in multiple myeloma: intranodal injections of idiotype-pulsed CD40 ligand-matured vaccines led to induction of type-1 and cytotoxic T-cell immune responses in patients